These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 725697)

  • 1. [Studies on the assay procedures for immune interferon and its determination on lymphocytes from patients with systemic lupus erythematosus (SLE) (author's transl)].
    Suzuki H
    Ryumachi; 1978 Sep; 18(5):308-16. PubMed ID: 725697
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the lysis of lymphocytes of patients with systemic lupus erythematosus--with relation to lymphocyte subpopulation (author's transl)].
    Tanaka Z
    Ryumachi; 1977 Jul; 17(4):388-95. PubMed ID: 302991
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunologic protection against Epstein-Barr virus induced oncogenesis: cooperative effect of lymphocytes, antibodies and interferon in healthy individuals (author's transl)].
    Aya T
    Hokkaido Igaku Zasshi; 1981 Nov; 56(6):587-96. PubMed ID: 6175556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lymphoreceptopathy in the patients with systemic lupus erythematosus (author's transl)].
    Arimori S
    Nihon Naika Gakkai Zasshi; 1980 Dec; 69(12):1584-9. PubMed ID: 7229477
    [No Abstract]   [Full Text] [Related]  

  • 5. [Detection of anti-lymphocyte antibody in SLE by double staining method (author's transl)].
    Nakai H; Nakamura T; Okudaira K; Hayakawa T; Tanimoto K; Horiuchi Y; Juji T
    Ryumachi; 1979 Feb; 19(1):31-6. PubMed ID: 85340
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect on lymphocytes from systemic lupus erythematosus patients on DNA synthesis in human bone marrow cells (author's transl)].
    Wakabayashi Y; Shiokawa Y; Takaku F
    Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):493-8. PubMed ID: 696192
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferons and systemic lupus erythematosus.
    Bankhurst AD
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():63-7. PubMed ID: 2441046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon inhibitor in the blood of patients with systemic lupus erythematosus.
    Chadha KC; Ambrus JL; Stadler I; Ambrus JL
    J Biol Regul Homeost Agents; 1991; 5(1):1-9. PubMed ID: 1715634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interferon and the pathogenesis of SLE].
    Schattner A; Bentwich Z
    Harefuah; 1982 Nov; 103(10):282-3. PubMed ID: 6189771
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody-dependent direct cytotoxicity of human lymphocytes. I. Studies on peripheral blood lymphocytes and sera of patients with systemic lupus erythematosus.
    Scheinberg MA; Cathcart ES
    Clin Exp Immunol; 1976 May; 24(2):317-22. PubMed ID: 1084243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of immune complexes in renal diseases (author's transl)].
    Smolen JS; Wolf A; Scherak O; Syre G; Pinggera W; Stummvoll HK; Leithner C; Menzel EJ
    Acta Med Austriaca; 1981; 8(2):37-41. PubMed ID: 6456639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to alpha-interferon in a patient with systemic lupus erythematosus.
    Panem S; Check IJ; Henriksen D; Vilcek J
    J Immunol; 1982 Jul; 129(1):1-3. PubMed ID: 6177744
    [No Abstract]   [Full Text] [Related]  

  • 14. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
    J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus.
    Emlen W; Niebur J; Kadera R
    J Immunol; 1994 Apr; 152(7):3685-92. PubMed ID: 8144943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic lupus erythematosus: all roads lead to type I interferons.
    Pascual V; Farkas L; Banchereau J
    Curr Opin Immunol; 2006 Dec; 18(6):676-82. PubMed ID: 17011763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear DNA degradation in lymphocytes of patients with systemic lupus erythematosus.
    Compton LJ; Steinberg AD; Sano H
    J Immunol; 1984 Jul; 133(1):213-6. PubMed ID: 6725954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mononuclear phagocytes from patients with active systemic lupus erythematosus down-regulate the specific in vitro reactivity of autologous lymphocytes to double-stranded DNA.
    Weill BJ; Renoux ML
    Clin Exp Immunol; 1988 Apr; 72(1):43-9. PubMed ID: 3293851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative characteristics of immunological tests in differentiation of systemic and cutaneous forms of lupus erythematosus].
    Romanova NV; Shilkina NP
    Ter Arkh; 2009; 81(4):40-3. PubMed ID: 19514420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Circulating interferon in patients with systemic lupus erythematosus. A prospective study].
    Dudli C; Kaiser V; Aguet M; Joller H; Pichler WI; Grob PJ; Fontana A
    Schweiz Med Wochenschr; 1986 Jan; 116(4):104-9. PubMed ID: 2419975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.